Browse > Article
http://dx.doi.org/10.4078/jrd.2011.18.1.55

A Case of Peritoneal Tuberculosis with Poncet's Disease in a Patient Treated with Infliximab  

Park, Hyo (Department of Internal Medicine, Eulji University School of Medicine)
Park, Chan-Woong (Department of Internal Medicine, Eulji University School of Medicine)
Kim, Ki-Bang (Department of Internal Medicine, Eulji University School of Medicine)
Lee, Min-Ji (Department of Internal Medicine, Eulji University School of Medicine)
Zeon, Seok-Jae (Department of Internal Medicine, Eulji University School of Medicine)
Shim, Seung-Cheol (Department of Internal Medicine, Eulji University School of Medicine)
Lim, Mi-Kyung (Department of Internal Medicine, Eulji University School of Medicine)
Sheen, Dong-Hyuk (Department of Internal Medicine, Eulji University School of Medicine)
Publication Information
Journal of Rheumatic Diseases / v.18, no.1, 2011 , pp. 55-59 More about this Journal
Abstract
Infliximab is a chimeric mouse/human monoclonal antibody against tumor necrosis factor-alpha (TNF-$\alpha$) that is used worldwide to treat rheumatic disease. However, the reactivation of tuberculosis, including extrapulmonary menifestation, is a severe side effect of anti-TNF-$\alpha$ treatment. Mycobacterium tubercluosis causes two forms of joint involvement, TB arthritis and Poncet's disease. Poncet's disease is a rare aseptic form of arthritis, known as reactive arthritis in tuberculosis. We encountered a case of tuberculous peritonitis with Poncet's disease in a 38-yearold man with a history of ankylosing spondylitis that was treated with infliximab. We report this case with a review of the literature.
Keywords
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001; 344:907-16.   DOI   ScienceOn
2 Cush JJ. Safety overview of new disease-modifying antirheumatic drugs. Rheum Dis Clin North Am 2004;30: 237-55.   DOI   ScienceOn
3 Seong SS, Choi CB, Woo JH, Bae KW, Joung CL, Uhm WS, et al. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. J Rheumatol 2007;34: 706-11.
4 Kroot EJ, Hazes JM, Colin EM, Dolhain RJ. Poncet's disease: reactive arthritis accompanying tuberculosis. Two case reports and a review of the literature. Rheumatology (Oxford) 2007;46:484-9.   DOI   ScienceOn
5 Dall L, Long L, Stanford J. Poncet's disease: tuberculous rheumatism. Rev Infect Dis 1989;11:105-7.   DOI
6 Hameed K, Karim M, Islam N, Gibson T. The diagnosis of Poncet's disease. Br J Rheumatol 1993;32:824-6.   DOI
7 Kwok SK, Park SH. Guidelines for Prevention of Tuberculosis in Patients with Rheumatoid Arthritis Treated with TNF-alpha Blockers. J Korean Rheum Assoc 2007;14:105- 11.   DOI   ScienceOn
8 Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-104.   DOI   ScienceOn
9 Poncet A. De la polyarthrite tuberculeuse deformante on pseudo-rheumatisme chronique tuberculeux. Congr Fr Chir 1897;2:732-4.
10 Summers GD, Jayson MI. Does Poncet's disease exist? Rheumatol Rehabil 1980;19:149-50.   DOI
11 Lee HL, Lee IH, Son BK, Jung JH, Kim TH, Yang SC, et al. A case of Poncet's disease with tuberculosis of the intestine and lymph nodes. Korean J Med 2001;61:211-4.
12 Park SS, Yun CY, Kang EH, Lee EY, Lee YJ, Lee EB,et al. A case of poncet's disease in a patient with pulmonary tuberculosis. J Korean Rheum Assoc 2010;17:183-7.   DOI   ScienceOn
13 Choi SW, Ahn JJ, Hwang YT, Koh SH, Cho SD. A case of tuberculous arthritis following the use of etanercept. Korean J Intern Med 2009;24:397-401.   DOI   ScienceOn
14 Klippel JH, Stone JH, Crofford LJ, White PH. Primer on the rheumatic diseases. 13th ed. p.193-9, New York, Springer, 2008.
15 Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al; American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society. American Thoracic Society/ Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-62.   DOI   ScienceOn